Laboratory News and Research

RSS

Clots, COVID-19 and survival

The novel coronavirus, now known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that causes COVID-19 disease, was first reported in Wuhan, Hubei Province of China in late December 2019. Since then, it has infected a large population across the world with the current number of SARS-CoV-2 infections standing at over 13 million and COVID-19 disease having killed over 571,000 individuals.

13 Jul 2020

Bat research critical to help predict and prevent the next pandemic

The current SARS-CoV-2 pandemic has a likely connection to bats, and the next viral outbreak probably will too, unless scientists can quickly learn more about the thousands of viruses carried by one of the most diverse mammals on the planet.

13 Jul 2020

Serology distinguishes children with MIS-C associated with COVID-19

Researchers in the United States say that measuring antibody titers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may help to distinguish between multisystem inflammatory syndrome in children (MIS-C) and other clinically similar syndromes.

13 Jul 2020

Study shows safety and effectiveness of PET radiotracer in imaging glioblastomas

A first-in-human study presented at the Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting has demonstrated the safety, favorable pharmacokinetic and dosimetry profile of 64Cu-EBRGD, a new, relatively long-lived PET tracer, in patients with glioblastomas.

13 Jul 2020

Fully automated chip can reliably determine blood type within minutes

The need to first zero in on a blood group can delay blood transfusions in emergency situations, and this in turn can prove fatal.

13 Jul 2020

Long-studied protein can be used as biomarker for traumatic brain injury

Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.

13 Jul 2020

Novel drug could enable the immune system to attack ovarian cancer

A drug known as SP-2577 could help enable the body's own immune system to attack ovarian cancer, according to a study led by the Translational Genomics Research Institute, an affiliate of City of Hope.

13 Jul 2020

High-resolution TB-PET/CT scanner reveals complete picture of systemic inflammatory arthritis

For the first time, physicians can examine the systemic burden of inflammatory arthritis simultaneously across all joints and organ systems, using the high-sensitivity, high-resolution uEXPLORER total-body positron emission tomography/computed tomography (TB-PET/CT) scanner.

13 Jul 2020

Developments in Separation Science

An interview with Daniel Armstrong about the evolution of separation science and its recent and future developments.

From Pittcon 13 Jul 2020

Researchers develop COVID-19 mortality risk calculator

A new study published in July 2020 on the preprint server medRxiv describes the use of machine learning to provide a better understanding of the risk factors in large and mixed groups. The use of algorithms can help objectively evaluate these factors and perhaps capture interactions that could be missed in a purely observational study.

13 Jul 2020

Working memory plays key role in social distancing compliance during COVID-19

Whether you decided to engage in social distancing in the early stages of COVID-19 depended on how much information your working memory could hold.

12 Jul 2020

UCR postdoctoral researcher receives 'Pathway to Independence' grant from NIH

Rebekah Charney, a postdoctoral researcher in the School of Medicine at the University of California, Riverside, has received a five-year "Pathway to Independence" grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health, or NIH.

12 Jul 2020

Face blindness may arise from deficits beyond visual perception

The ability to recognize faces is a complex neurocognitive skill with important social implications. The disorder, which, according to some estimates, affects more than 2 percent of the population, can lead to isolation and anxiety and impair personal and work relationships.

12 Jul 2020

New mutation in common subtype of influenza virus helps evade immune response

Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

12 Jul 2020

New biomarker could be an early indicator of cognitive decline

Medical researchers in the UK and Australia have identified a new marker which could support the search for novel preventative and therapeutic treatments for dementia.

11 Jul 2020

Newly discovered chemical compound shows potential to become treatment for brain disorders

Researchers at IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology) discovered a novel chemical compound, which has the potential to became a new drug for the treatment of core symptoms of brain disorders like Down syndrome and autism.

11 Jul 2020

USC scientists may have found a path toward increasing human lifespan

Scientists at USC Dornsife College of Letters, Arts and Sciences may have found the beginnings of a path toward increasing human lifespan.

11 Jul 2020

Next-generation SCIEX 7500 System launches at virtual product experience

SCIEX, a global leader in life science analytical technologies, launches the next generation of its flagship nominal mass spectrometer, the SCIEX Triple Quad 7500 LC-MS/MS System – QTRAP Ready.

10 Jul 2020

FIND and Unitaid launch call for EOI to fill major diagnostic gaps in COVID-19 detection

The Foundation for Innovative New Diagnostics and Unitaid announced today that the organizations have launched a call for expressions of interest to accelerate the availability and manufacturing scale-up of rapid diagnostic tests for the detection of SARS-CoV-2 antigens. Reliable, affordable Ag RDTs have been identified as key tools in the global response to COVID-19, as they could enable robust detection of active SARS-CoV-2 infection for both patient management and contact tracing purposes in decentralized settings.

10 Jul 2020

Researchers set up Gate2Brain to exploit a novel drug-transporting technology

Researchers from IRB Barcelona, the University of Barcelona (UB) and the Sant Joan de Déu Research Institute - Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel technology developed at IRB Barcelona to transport drugs into the brain.

10 Jul 2020